Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for MariMed Inc. (MRMD : OTC)

• Company Description    MariMed Inc. is a multi-state cannabis operator. The Company develops, owns and manages seed to sale state-licensed cannabis facilities, which are models in horticultural principles, cannabis cultivation, cannabis-infused products and dispensary operations. Its products and brands, includes Betty's Eddies(R), Nature's Heritage(TM), Bourne Baking Co. and K-Fusion(R). MariMed Inc. is based in NORWOOD, Mass. Number of Employees: 923

• Price / Volume Information    Yesterday's Closing Price: $0.08 Daily Weekly Monthly 20 Day Moving Average: 325,986 shares Shares Outstanding: 397.72 (millions) Market Capitalization: $30.15 (millions) Beta: 1.11 52 Week High: $0.23 52 Week Low: $0.07 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -5.25% 2.78% 12 Week -19.36% -13.33% Year To Date -19.36% -12.30%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 10 Oceana Way - Norwood,MA 02062 USA ph: 781-277-0007 fax: - ir@marimedinc.com http://www.marimedinc.com

• General Corporate Information    Officers Jon R. Levine - President and Chief Executive Officer Edward Gildea - Chairman of the Board and Director Mario Pinho - Chief Financial Officer David Allen - Director Eva Selhub - Director Peer Information MariMed Inc. (BJCT) MariMed Inc. (CADMQ) MariMed Inc. (APNO) MariMed Inc. (UPDC) MariMed Inc. (IMTIQ) MariMed Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 56782V107 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 12/01/25 Next Expected EPS Date: 05/06/26 Share - Related Items Shares Outstanding: 397.72 Most Recent Split Date: (:1) Beta: 1.11 Market Capitalization: $30.15 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.01 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.05 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 05/06/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.60 Price/Cash Flow: 3.27 Price / Sales: 0.19 EPS Growth vs. Year Ago Period: 200.00% vs. Previous Quarter: 200.00% Sales Growth vs. Year Ago Period: 6.79% vs. Previous Quarter: 2.17% ROE 12/31/25 - -5.85 09/30/25 - -14.76 06/30/25 - -10.57 ROA 12/31/25 - -1.58 09/30/25 - -4.12 06/30/25 - -3.10 Current Ratio 12/31/25 - 1.00 09/30/25 - 1.06 06/30/25 - 1.12 Quick Ratio 12/31/25 - 0.38 09/30/25 - 0.35 06/30/25 - 0.36 Operating Margin 12/31/25 - -2.03 09/30/25 - -5.41 06/30/25 - -4.10 Net Margin 12/31/25 - -8.94 09/30/25 - -11.36 06/30/25 - -10.14 Pre-Tax Margin 12/31/25 - -6.80 09/30/25 - -4.39 06/30/25 - -4.49 Book Value 12/31/25 - 0.13 09/30/25 - 0.14 06/30/25 - 0.15 Inventory Turnover 12/31/25 - 2.66 09/30/25 - 2.59 06/30/25 - 2.66 Debt-to-Equity 12/31/25 - 1.44 09/30/25 - 1.34 06/30/25 - 1.25 Debt-to-Capital 12/31/25 - 59.06 09/30/25 - 57.35 06/30/25 - 55.57

Powered by Zacks Investment Research ©